Back
  1. Home
  2. Profile of Xiaobing QING (Unilu)
Profil

QING Xiaobing

Main Referenced Co-authors
SCHWAMBORN, Jens Christian  (2)
Alexakos, Pavlos (1)
ARIAS, Jonathan  (1)
Asvos, Xenophon (1)
Cournia, Zoe (1)
Main Referenced Keywords
a-Synuclein (1); CRISPR/Cas9 (1); disease modeling (1); dopaminergic neurons (1); Genome editing (1);
Main Referenced Unit & Research Centers
Luxembourg Centre for Systems Biomedicine (LCSB): Developmental and Cellular Biology (Schwamborn Group) (1)
Main Referenced Disciplines
Genetics & genetic processes (2)
Life sciences: Multidisciplinary, general & others (1)

Publications (total 3)

The most downloaded
3 downloads
ARIAS, J., JARAZO, J., QING, X., WALTER, J., GOMEZ GIRO, G., NICKELS, S., Zaehres, H., Schoeler, H. R., & SCHWAMBORN, J. C. (2017). FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling. Stem Cell Reports. doi:10.1016/j.stemcr.2017.08.026 https://hdl.handle.net/10993/32572

The most cited

77 citations (OpenAlex)

ARIAS, J., JARAZO, J., QING, X., WALTER, J., GOMEZ GIRO, G., NICKELS, S., Zaehres, H., Schoeler, H. R., & SCHWAMBORN, J. C. (2017). FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling. Stem Cell Reports. doi:10.1016/j.stemcr.2017.08.026 https://hdl.handle.net/10993/32572

QING, X. (2017). CRISPR/CAS9 AND PIGGYBAC MEDIATED LRRK2-G2019S IN VITRO PARKINSON’S DISEASE MODELING [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/31956

ARIAS, J., JARAZO, J., QING, X., WALTER, J., GOMEZ GIRO, G., NICKELS, S., Zaehres, H., Schoeler, H. R., & SCHWAMBORN, J. C. (2017). FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling. Stem Cell Reports. doi:10.1016/j.stemcr.2017.08.026
Peer Reviewed verified by ORBi

Spathis, A., Asvos, X., Ziavra, D., Karampelas, T., Topouzis, S., Cournia, Z., QING, X., Alexakos, P., SMITS, L., Dalla, C., Rideout, H., SCHWAMBORN, J. C., Tamvakopoulos, C., Fokas, D., & Vassilatis, D. (2017). Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America. doi:10.1073/pnas.1616874114
Peer Reviewed verified by ORBi

Contact ORBilu